Bristol Gate Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.3M | Buy |
173,498
+11,183
| +7% | +$4.53M | 4% | 19 |
|
|
2025
Q1 | $80.8M | Buy |
162,315
+2,011
| +1% | +$1M | 3.94% | 18 |
|
|
2024
Q4 | $83.4M | Sell |
160,304
-3,745
| -2% | -$1.95M | 4.06% | 18 |
|
|
2024
Q3 | $101M | Sell |
164,049
-685
| -0.4% | -$424K | 4.65% | 11 |
|
|
2024
Q2 | $91.1M | Sell |
164,734
-8,665
| -5% | -$4.79M | 4.51% | 11 |
|
|
2024
Q1 | $101M | Buy |
173,399
+17
| +0% | +$9.88K | 4.73% | 5 |
|
|
2023
Q4 | $92M | Buy |
173,382
+23,301
| +16% | +$12.4M | 4.59% | 11 |
|
|
2023
Q3 | $76M | Sell |
150,081
-4,404
| -3% | -$2.23M | 4.23% | 18 |
|
|
2023
Q2 | $80.6M | Sell |
154,485
-2,586
| -2% | -$1.35M | 4.24% | 16 |
|
|
2023
Q1 | $90.5M | Sell |
157,071
-2,182
| -1% | -$1.26M | 4.9% | 6 |
|
|
2022
Q4 | $87.7M | Sell |
159,253
-3,636
| -2% | -$2M | 5.01% | 4 |
|
|
2022
Q3 | $82.6M | Sell |
162,889
-4,474
| -3% | -$2.27M | 5.08% | 4 |
|
|
2022
Q2 | $90.9M | Sell |
167,363
-2,660
| -2% | -$1.45M | 5.14% | 5 |
|
|
2022
Q1 | $100M | Sell |
170,023
-6,829
| -4% | -$4.03M | 4.92% | 5 |
|
|
2021
Q4 | $118M | Buy |
176,852
+1,072
| +0.6% | +$715K | 5.31% | 2 |
|
|
2021
Q3 | $100M | Buy |
175,780
+4,656
| +3% | +$2.66M | 5.16% | 3 |
|
|
2021
Q2 | $86.3M | Buy |
171,124
+23,451
| +16% | +$11.8M | 4.52% | 11 |
|
|
2021
Q1 | $67.4M | Buy |
+147,673
| New | +$67.4M | 4.02% | 21 |
|